- Certified™: February 2025
Anti-obesity Medications: Best Practices and a Glimpse Into the Future
The landscape of GLP-1 receptor agonists and other anti-obesity medications (AOMs) such as Ozempic, Wegovy, and Mounjaro is rapidly evolving. This in-depth Q&A with Dr. Michael Hosking, an expert in obesity medications and exercise science, discusses the intersection of fitness and medicine in the context of these drugs, as well as best practices for working with clients taking AOMs, exercise programming considerations and the future implications of these medications for the fitness industry.
Read More